Performance characteristics of the EIAgen hepatitis C virus antibody kit assay
RAO Hui-ying,GUAN Wen-li,REN Fu-rong,DU Shao-cai,LIU Chang-li,YU Yang,GU Jin-lian,GONG Xiao-yan,YANG Zhen,QI Zi-bai,WEI L,饶慧瑛,管文莉,任芙蓉,杜绍财,刘长丽,于洋,谷金莲,龚晓燕,杨振,祁自柏,魏来
DOI: https://doi.org/10.3760/J.ISSN:1009-9158.2007.10.016
2007-01-01
Abstract:Objective To compare the performance of EIAgen HCV kit(EIAgen HCV)versus the current Ortho HCV 3.0 Anti-HCV(Ortho 3.0 HCV)assay in various clinical settings,such as blood banks and hepatology centers.Methods The two ELISA kits were evaluated simultaneously using a total of 2 881 specimens.All the results concordant positive for both assays and Ortho HCV result beyond 3.8 were classified as true positive(TP)or concordant negative for both assays as true negative(TN).The discordant specimens were further comfirmed using either RIBA 3.0 or a homebrew nucleic acid testing(NAT) assay.Results Among the 2 881 specimens evaluated,274 specimens were TP,2 539 specimens were TN, and 9 cases were indeterminate.The sensitivity of EIAgen HCV was 100%,versus 98.91% for Ortho HCV while their respective speeificities were 99.53% and 99.88%.Positive predictive and negative predictive values of 95.80% and 100% were respectively obtained for EIAgen HCV assay.Overall,the accuracy was 99.57%.Specimens under various conditions containing potentially interfering substances,such as acute non-C hepatitis,autoimmune diseases,pregnant women,hemolysis,and lipoidemia,showed no interference with the two ELISAs.EIAgen HCV S/CO ratio values more than 5.9 would be highly predictive for the TP status of these specimens.Conclusions Our findings indicate that EIAgen HCV Kit is more sensitive than Ortho HCV 3.0 Test in detecting antibodies to HCV.EIAgen HCV Kit appears to be an excellent tool,not only for use in diagnostic settings,but also ideally suited for the screening of blood and blood products.